Gestational exposure to elevated testosterone levels induces hypertension via heightened vascular angiotensin II type 1 receptor signaling in rats

Biology of Reproduction

Volumn 91, Issue 1, 2014, Pages

  Chinnathambi, Vijayakumar ^a   More, Amar S ^a   Hankins, Gary D ^a   Yallampalli, Chandra ^b   Sathishkumar, Kunju ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AGTR1; angiotensin; blood pressure; losartan; mesenteric arteries; pre eclampsia; pregnancy; testosterone; vascular function

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN; PHENYLEPHRINE; TESTOSTERONE; TESTOSTERONE PROPIONATE; ANGIOTENSIN II;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CONTROLLED STUDY; DRUG MECHANISM; FEEDING; FEMALE; GESTATION PERIOD; MATERNAL HYPERTENSION; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; TESTOSTERONE BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; HYPERTENSION, PREGNANCY-INDUCED; METABOLISM;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; LOSARTAN; MESENTERIC ARTERIES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; TESTOSTERONE;

EID: 84906256475     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.114.118968     Document Type: Article

References (62)

1. Steegers EA, von DP, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376:631-644.
2. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol 2001; 184:946-953.
3. Morsing E, Marsal K. Pre-eclampsia-an additional risk factor for cognitive impairment at school age after intrauterine growth restriction and very preterm birth. Early Hum Dev 2014; 90:99-101.
4. Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev 2009; 6(suppl 3): 332-336.
5. Fraser A, Nelson SM, Macdonald-Wallis C, Sattar N, Lawlor DA. Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension 2013; 62:614-620.
6. McDonnold M, Tamayo E, Kechichian T, Gamble P, Longo M, Hankins GD, Saade GR, Costantine MM. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. Am J Obstet Gynecol 2014; 210:542.e1-7.
7. Ryckman KK, Borowski KS, Parikh NI, Saftlas AF. Pregnancy complications and the risk of metabolic syndrome for the offspring. Curr Cardiovasc Risk Rep 2013; 7:217-223.
8. Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 2007; 106:c72-c81.
9. Atamer Y, Erden AC, Demir B, Kocyigit Y, Atamer A. The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women. Acta Obstet Gynecol Scand 2004; 83:425-430.
10. Ficicioglu C, Kutlu T. The role of androgens in the aetiology and pathology of pre-eclampsia. J Obstet Gynaecol 2003; 23:134-137.
11. Ghorashi V, Sheikhvatan M. The relationship between serum concentration of free testosterone and pre-eclampsia. Endokrynol Pol 2008; 59: 390-392.
12. Lorzadeh N, Kazemirad S. The effects of fetal gender on serum human chorionic gonadotropin and testosterone in normotensive and preeclamptic pregnancies. J Pregnancy 2012; 2012:874290.
13. Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G. Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 126:16-19.
14. Serin IS, Kula M, Basbug M, Unluhizarci K, Gucer S, Tayyar M. Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery. Acta Obstet Gynecol Scand 2001; 80:1009-1013.
15. Sharifzadeh F, Kashanian M, Fatemi F. A comparison of serum androgens in pre-eclamptic and normotensive pregnant women during the third trimester of pregnancy. Gynecol Endocrinol 2012; 28:834-836.
16. Miller NR, Garry D, Cohen HW, Figueroa R. Serum androgen markers in preeclampsia. J Reprod Med 2003; 48:225-229.
17. Jirecek S, Joura EA, Tempfer C, Knofler M, Husslein P, Zeisler H. Elevated serum concentrations of androgens in women with pregnancyinduced hypertension. Wien Klin Wochenschr 2003; 115:162-166.
18. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002; 17:2573-2579.
19. Naver K, Grinsted J, Larsen S, Hedley P, Jorgensen F, Christiansen M, Nilas L. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG 2014; 30:311-315.
20. Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, Chen HY. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 2013; 11:56.
21. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011; 204:558.e1-558.e6.
22. Sathishkumar K, Balakrishnan M, Chinnathambi V, Chauhan M, Hankins GD, Yallampalli C. Fetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia. J Perinatol 2011; 32:328-335.
23. Hertig A, Liere P, Chabbert-Buffet N, Fort J, Pianos A, Eychenne B, Cambourg A, Schumacher M, Berkane N, Lefevre G, Uzan S, Rondeau E, et al. Steroid profiling in preeclamptic women: evidence for aromatase deficiency. Am J Obstet Gynecol 2010; 203:477-479.
24. Hsu TY, Lan KC, Tsai CC, Ou CY, Cheng BH, Tsai MY, Kang HY, Tung YH, Wong YH, Huang KE. Expression of androgen receptor in human placentas from normal and preeclamptic pregnancies. Taiwan J Obstet Gynecol 2009; 48:262-267.
25. Chinnathambi V, Balakrishnan M, Ramadoss J, Yallampalli C, Sathishkumar K. Testosterone alters maternal vascular adaptations: role of the endothelial NO system. Hypertension 2013; 61:647-654.
26. Sathishkumar K, Elkins R, Chinnathambi V, Gao H, Hankins GD, Yallampalli C. Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport. Reprod Biol Endocrinol 2011; 9:1-12.
27. Palomba S, Russo T, Falbo A, Di CA, Amendola G, Mazza R, Tolino A, Zullo F, Tucci L, La Sala GB. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. J Clin Endocrinol Metab 2012; 97:2441-2449.
28. August P, Lenz T, Ales KL, Druzin ML, Edersheim TG, Hutson JM, Muller FB, Laragh JH, Sealey JE. Longitudinal study of the reninangiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990; 163:1612-1621.
29. Brown MA, Nicholson E, Gallery ED. Sodium-renin-aldosterone relations in normal and hypertensive pregnancy. Br J Obstet Gynaecol 1988; 95: 1237-1246.
30. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-251.
31. Yoshida H, Kakuchi J, Guo DF, Furuta H, Iwai N, van der Meer-de Jong, Inagami T, Ichikawa I. Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem Biophys Res Commun 1992; 186:1042-1049.
32. Poduri A, Owens AP, III, Howatt DA, Moorleghen JJ, Balakrishnan A, Cassis LA, Daugherty A. Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS One 2012; e484621-e48462
33. Swafford AN Jr, Harrison-Bernard LM, Dick GM. Knockout mice reveal that the angiotensin II type 1B receptor links to smooth muscle contraction. Am J Hypertens 2007; 20:335-337.
34. Coffman TM. Gene targeting in physiological investigations: studies of the renin-angiotensin system. Am J Physiol 1998; 274:F999-1005.
35. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52:2682-2689.
36. Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 2010; 55: 1239-1245.
37. Leung PS, Tsai SJ, Wallukat G, Leung TN, Lau TK. The upregulation of angiotensin II receptor AT(1) in human preeclamptic placenta. Mol Cell Endocrinol 2001; 184:95-102.
38. Doering TP, Haller NA, Montgomery MA, Freeman EJ, Hopkins MP. The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1998; 178:1307-1312.
39. Nalogowska-Glosnicka K, Lacka BI, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E, Poreba R, Michalski B, Kniazewski B, Rzempoluch J. Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. Med Sci Monit 2000; 6:523-529.
40. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103:945-952.
41. Song J, Kost CK, Jr., Martin DS. Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1608-R1615.
42. Ojeda NB, Royals TP, Black JT, Dasinger JH, Johnson JM, Alexander BT. Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring. Am J Physiol Regul Integr Comp Physiol 2010; 298:R1421-R1427.
43. Freshour JR, Chase SE, Vikstrom KL. Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice. Am J Physiol Heart Circ Physiol 2002; 283:H1997-H2003.
44. Hilliard LM, Sampson AK, Brown RD, Denton KM. The "his and hers" of the renin-angiotensin system. Curr Hypertens Rep 2013; 15:71-79.
45. Leung PS, Wong TP, Chung YW, Chan HC. Androgen dependent expression of AT1 receptor and its regulation of anion secretion in rat epididymis. Cell Biol Int 2002; 26:117-122.
46. Sathishkumar K, Elkins R, Yallampalli U, Balakrishnan M, Yallampalli C. Fetal programming of adult hypertension in female rat offspring exposed to androgens in utero. Early Hum Dev 2011; 87:407-414.
47. Kalk P, Sharkovska Y, Kashina E, von Websky K, Relle K, Pfab T, Alter M, Guillaume P, Provost D, Hoffman K, Fischer Y, Hocher B. Endothelinconverting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner. Hypertension 2011; 57:755-763.
48. Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA. Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28:1251-1256.
49. Wasteson P, Johansson BR, Jukkola T, Breuer S, Akyurek LM, Partanen J, Lindahl P. Developmental origin of smooth muscle cells in the descending aorta in mice. Development 2008; 135:1823-1832.
50. Adler AJ, Danielsen M, Robins DM. Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc Natl Acad Sci U S A 1992; 89:11660-11663.
51. Bogdarina IG, King PJ, Clark AJ. Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids. J Mol Endocrinol 2009; 43:73-80.
52. McEwan IJ, Gustafsson J. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc Natl Acad Sci U S A 1997; 94:8485-8490.
53. Guo DF, Inagami T. The genomic organization of the rat angiotensin II receptor AT1B. Biochim Biophys Acta 1994; 1218:91-94.
54. Lee DK, Chang C. Molecular communication between androgen receptor and general transcription machinery. J Steroid Biochem Mol Biol 2003; 84:41-49.
55. Nickenig G, Strehlow K, Wassmann S, Baumer AT, Albory K, Sauer H, Bohm M. Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells. Circulation 2000; 102:1828-1833.
56. Song J, Kost CK Jr, Martin DS. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway. Cardiovasc Res 2006; 72:456-463.
57. Fix C, Jordan C, Cano P, Walker WH. Testosterone activates mitogenactivated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells. Proc Natl Acad Sci U S A 2004; 101: 10919-10924.
58. Sun M, Yang L, Feldman RI, Sun XM, Bhalla KN, Jove R, Nicosia SV, Cheng JQ. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J Biol Chem 2003; 278:42992-43000.
59. Bagi Z, Feher A, Cassuto J, Akula K, Labinskyy N, Kaley G, Koller A. Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes-role for Rho-kinase activation. Br J Pharmacol 2011; 163:1059-1068.
60. Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 2009; 296: H1425-H1433.
61. Song J, Eyster KM, Kost CK Jr, Kjellsen B, Martin DS. Involvement of protein kinase C-CPI-17 in androgen modulation of angiotensin II-renal vasoconstriction. Cardiovasc Res 2010; 85:614-621.
62. Touyz RM, Endemann D, He G, Li JS, Schiffrin EL. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999; 33:366-372.